🇯🇵 Laserphyrin in Japan

PMDA authorised Laserphyrin on 26 October 2003

Marketing authorisations

PMDA — authorised 26 October 2003

  • Marketing authorisation holder: Meiji Seika Pharm
  • Status: approved

Laserphyrin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Laserphyrin approved in Japan?

Yes. PMDA authorised it on 26 October 2003; PMDA has authorised it.

Who is the marketing authorisation holder for Laserphyrin in Japan?

Meiji Seika Pharm holds the Japanese marketing authorisation.